Medtech company PainTEQ has commercially launched TRAQ SI Joint Fusion, which is designed to engage the sacral and iliac cortices for bi-cortical fixation.
The posterior SI joint implant is delivered through a tissue-sparring, 1-inch incision. By engaging the acral and iliac cortices, the joint is transfixed at the two anatomic surfaces where mechanical purchase is strongest, according to a May 15 news release from PainTEQ.
Timothy Deer, MD, CEO of Charleston, W.Va.-based The Spine and Nerve Center of the Virginias and founder of the American Society of Pain and Neuroscience, performed the first procedure with the TRAQ implant.
PainTEQ has also launched a prospective, multicenter, post-market study to evaluate the safety and efficacy of the implant. The study is expected to enroll up to 100 patients across 10 sites in the U.S., the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
